Large clinical trials can be particularly useful in the early treatment and prevention of neurodegenerative diseases because of the amount of data collected, though patient recruitment and retention are challenging, says biostatistician.
Schwarz Pharma's foray into the central nervous system
disorder market is beginning to pay serious dividends as the
firm's ground-breaking transdermal patch for Parkinson's continues
to prove a success story, now gaining...
Scientists researching pharmaceutical treatments for Parkinson's
disease are invited to submit study information to a new patient
website, which is intended to improve access to information on
Parkinson's clinical trials,...
Research that could eventually lead to gene therapy treatment
options for patients with Parkinson's disease has been published
this week, which could bring hope to more than 1 million Americans
each year who suffer from this...